Analyzing all 73 lesions (> 4.2 mL) from 26 patients showed that the geometric mean SUVpeak per patient increased by 4% (95%CI −2 to 11%; P = 0.17) per doubling in (EGFR + 1) score, assuming identical EGFR expression in all tumor lesions per patient (Fig. S7B). This evidence concerns the gene EGFR and neoplasm.